Click here for slides on this topic


70/30 insulin

Premixed insulin that is 70 percent intermediate-acting (NPH) insulin and 30 percent rapid-acting (regular) insulin.
The following content matched the glossary term: 70/30 insulin

ADA 2016 Type 2 Diabetes Pharmacologic Therapy

Top

Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 10, 2012

Top

Daily coverage from the American Diabetes Association 72nd Scientific Sessions June 10, 2012

Beta-cell function preservation, ACCORD-BP, update on insulin therapies for diabetes treatment, pharmacology for diabetes prevention, and more. 

Preoperative hypoglycemia in a patient receiving insulin detemir

Top

Olson RP, Bethel MA, Lien L. Preoperative hypoglycemia in a patient receiving insulin detemir. Anesth Analg. 2009;108(6):1836-1838. The insulin regimen of a type 2 diabetic presenting for surgery had been changed recently from a 70/30 mixture of insulin aspart protamine and aspart to insulin detemir and insulin glulisine.

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US

Top

Ray JA, Valentine WJ, Roze S, et al. Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes, Obesity and Metabolism. 2007;9:103-113. To project the long-term clinical and economic outcomes of treatment with biphasic insulin aspart 30 (BIAsp 70/30, 30% soluble and 70% protaminated insulin aspart) vs. insulin glargine in insulin-naive type 2 diabetes patients failing to achieve glycemic control with oral antidiabetic agents alone.

Improved Postprandial Glycemic Control During Treatment With Humalog Mix25, a Novel Protamine-Based Insulin Lispro Formulation

Top

Roach P, Yue L, Arora V. The Humalog Mix25 Study Group. Improved Postprandial Glycemic Control During Treatment With Humalog Mix25, a Novel Protamine-Based Insulin Lispro Formulation. Diabetes Care. 1999;22:1258-1261. Humalog Mix25 is a manufactured premixed insulin formulation containing insulin lispro and a novel insulin lispro-protamine formulation (NPL) in a ratio of 25:75%. The objective of this study was to compare Humalog Mix25 to human insulin 30/70 (30% regular insulin/70% NPH) with respect to glycemic control.

Product Indications

Top

Medications used to treat diabetes :: Alpha-glucosidase inhibitors, amylin mimetics, biguanides (metformin), bile acid sequestrants, dopamine receptor agonists, DPP-4 inhibitors, GLP-1 analogs, incretins, insulin, meglitinides, SGLT2 inhibitors, sulphonylureas, thiazolidinediones (TZDs).



Slide Library Results

Search Results for: 7030 insulin Slides Found: 0